Genvax Technologies

Develops mRNA nanoparticle vaccines for animals

Bioinformatics/AI Intern

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours

Internship · Summer 2027Ames, IA, USA$16 - $17 /hr

About the Job

Requirements

Pursuit of an Associate’s, Bachelor’s, Master’s, or Doctoral degree in Bioinformatics, Computer Science, Computer Engineering, Molecular Biology, Genetics, or a closely related quantitative or life sciences discipline.
Strong attention to detail.
Demonstrated ability to learn and apply new skill sets quickly.
Experience managing independent projects.

Responsibilities

Explore, evaluate, and apply emerging artificial intelligence technologies to enhance vaccine candidate design, automate routine laboratory workflows, and support data interpretation.
Help design and develop internal- and external-facing web applications.
Build bioinformatics tools for sequence analysis and improved vaccine design.
Prototype and improve machine learning algorithms.
Deliver an independent project and present results to the Genvax team.
Follow standard operating procedures and documentation standards in a regulated environment; maintain detailed project notes and version-controlled code.
Contribute to continuous improvement across tools and processes for internal users.
Perform other duties as assigned in a dynamic startup setting.

Desired Qualifications

Preference will be given to students attending an Iowa college or university, or students who graduated from an Iowa high school and attend a college or university outside of Iowa.
Bioinformatics, coding, or software development experience is preferred.
Experience with machine learning, artificial intelligence, or predictive analytics is a plus.

Bioinformatics/AI Intern

Genvax Technologies · Ames, United States · Full-time · Posted 2026-10-06

Salary: USD 16–17

Workplace: on_site

Description

Overview:

Genvax Technologies is a startup animal health company focused on developing self-amplifying mRNA nanoparticle vaccines. Genvax Technologies seeks a Summer 2027 Bioinformatics/AI Intern at our Ames, IA location. Your project will include assisting in the development and validation of vaccine technologies to improve animal health. You will work closely with a mentor to develop and execute an independent project. This is a unique opportunity to work in the early stages of a startup company. This is a paid internship that runs from May 24th to August 13th (dates flexible).

Essential Job Functions:

Explore, evaluate, and apply emerging AI technologies to enhance vaccine candidate design, automate routine laboratory workflows, and support data interpretation
Help design and develop internal and external facing web applications
Build bioinformatic tools for sequence analysis and improved vaccine design
Prototype and improve machine learning algorithms
Deliver an independent project and present results to the Genvax team
Follow SOPs and documentation standards in a regulated environment; maintain detailed project notes and version-controlled code.
Contribute to continuous improvement across tools and processes for internal users
Perform other duties as assigned in a dynamic startup setting

Requirements

Pursuit of an Associate’s, Bachelor’s, Master’s, or Doctoral degree in Bioinformatics, Computer Science/Engineering, Molecular Biology, Genetics, or a closely related quantitative or life sciences discipline
Preference will be given to students attending an Iowa college or university, or students that have graduated from an Iowa high school and attend a college or university outside of Iowa
Bioinformatics, coding, or software development experience is preferred
Experience with machine learning, artificial intelligence, or predictive analytics is a plus
Strong attention to detail
Demonstrated ability to learn and apply new skill sets quickly
Experience managing independent projects

Benefits

Paid Internship. $16-$17 per hour, with 30-40 hours per week.
We are willing to work with your department if you need this internship to count for credit, depending on the requirements

Apply

Apply at Genvax Technologies

About the Company

Genvax Technologies

Develops mRNA nanoparticle vaccines for animals

Genvax Technologies develops mRNA nanoparticle vaccines for animals to prevent and treat veterinary diseases, serving livestock producers, clinics, and animal health organizations. Its vaccines use an mRNA platform packaged in nanoparticles to trigger an immune response, with products advanced through R&D and then sold commercially. The company differentiates itself with a founder-led team tied to a proven track record in animal vaccines and a rapid-response approach to new animal health challenges. Its goal is to improve global animal health by quickly bringing effective animal vaccines to market.

Company size: 1-10
Company stage: Early VC
Total funding: $10.1M
Headquarters: Ames, IA
Founded: 2021

Recently Posted Jobs

Explore more opportunities at Genvax Technologies

See more jobs